Literature DB >> 29192796

The effect of weight loss on body composition, serum bone markers, and adipokines in prepubertal obese children after 1-year intervention.

Joanna Gajewska1, Jadwiga Ambroszkiewicz1, Witold Klemarczyk2, Magdalena Chełchowska1, Halina Weker2, Katarzyna Szamotulska3.   

Abstract

Purpose/Aim: The influence of weight loss on bone turnover and bone quality in childhood remains controversial, but it may implicate interactions between adiposity and bone metabolism. Therefore, we studied the relationships between bone markers and adipokines during weight loss in obese children.
MATERIALS AND METHODS: We determined serum leptin, soluble leptin receptor, adiponectin, bone alkaline phosphatase (BALP), C-terminal telopeptide of type I collagen (CTX-I), osteocalcin (OC), carboxylated-OC (Gla-OC), undercarboxylated-OC (Glu-OC), sclerostin, body composition, and bone mineral density (BMD) in 40 obese prepubertal children before and after therapy. The control group, matched for sex and age, consisted of 40 non-obese children.
RESULTS: We found that values of the total body less head-bone mineral content (TBLH-BMC) and TBLH-BMD were significantly increased, but TBLH-BMD Z-score was decreased by 25% (p = 0.002) in obese children with weight loss after therapy. We observed increases of CTX-I to OC ratio (p = 0.009), and Gla-OC concentrations (p = 0.049). Changes in TBLH-BMD Z-score in patients were positively correlated with changes in BMI Z-score (p = 0.001), percentage of fat mass (p = 0.004), and BALP activity (p = 0.01). Changes in BALP activity were negatively correlated (p < 0.001) with changes in adiponectin concentrations, while changes in sclerostin levels were positively correlated (p = 0.001) with leptin changes.
CONCLUSIONS: We suggest that alterations in adipokines metabolism were associated with a lower rate of bone mineral accrual as a result of decreased bone formation rather than increased bone resorption. The lower rate of bone mass accrual in weight losing children may be an effect of reduced BALP levels related to increase in adiponectin levels.

Entities:  

Keywords:  Weight loss therapy; adipokines; bone turnover; prepubertal period

Mesh:

Substances:

Year:  2017        PMID: 29192796     DOI: 10.1080/07435800.2017.1403444

Source DB:  PubMed          Journal:  Endocr Res        ISSN: 0743-5800            Impact factor:   1.720


  6 in total

Review 1.  Bone Turnover Markers in Children: From Laboratory Challenges to Clinical Interpretation.

Authors:  Aurélie Ladang; Frank Rauch; Edgard Delvin; Etienne Cavalier
Journal:  Calcif Tissue Int       Date:  2022-03-04       Impact factor: 4.333

2.  Value of pre-operative CTX serum levels in the prediction of medication-related osteonecrosis of the jaw (MRONJ): a retrospective clinical study.

Authors:  Martin Salgueiro; Michael Stribos; Li Fang Zhang; Mark Stevens; Mohamed E Awad; Mohammed Elsalanty
Journal:  EPMA J       Date:  2019-01-24       Impact factor: 6.543

Review 3.  The effect of exercise training on osteocalcin, adipocytokines, and insulin resistance: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Gh R Mohammad Rahimi; A Niyazi; S Alaee
Journal:  Osteoporos Int       Date:  2020-08-15       Impact factor: 4.507

4.  The Effect of BMI, Age, Gender, and Pubertal Stage on Bone Turnover Markers in Chinese Children and Adolescents.

Authors:  Bingyan Cao; Meijuan Liu; Qipeng Luo; Qiao Wang; Min Liu; Xuejun Liang; Di Wu; Wenjing Li; Chang Su; Jiajia Chen; Chunxiu Gong
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-13       Impact factor: 6.055

5.  Relationships between Body Weight Status and Serum Levels of Adipokine, Myokine and Bone Metabolism Parameters in Healthy Normal Weight and Thin Children.

Authors:  Jadwiga Ambroszkiewicz; Magdalena Chełchowska; Joanna Mazur; Grażyna Rowicka; Joanna Gajewska
Journal:  J Clin Med       Date:  2022-07-11       Impact factor: 4.964

Review 6.  The Bones of Children With Obesity.

Authors:  Danilo Fintini; Stefano Cianfarani; Marta Cofini; Angela Andreoletti; Grazia Maria Ubertini; Marco Cappa; Melania Manco
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-24       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.